Hemostasis Diagnostics Market

Hemostasis Diagnostics Market (Product Type - Laboratory Systems, Consumables, and Point-of-Care Testing Systems; Test Type - Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer; End Users - Hospital/Clinics, Independent Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL1503
  • Published On : Oct 2017
  • No. of Pages : 189
  • Category : Healthcare

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Hemostasis Diagnostics: Market Snapshot
3.2 Market Share Analysis by Region, 2016
3.3 Market Opportunity Map

Section 4 Market Overview
4.1 Market Overview
4.2 Global Hemostasis Diagnostics Market: Market Indicators
4.3 Global Hemostasis Diagnostics Market: Key Industry Developments
4.4 Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
4.5 Global Hemostasis Diagnostics Market: Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
       5.2.1 Rise in prevalence of blood clotting disorders
       5.2.2 High prevalence of cardiovascular diseases
       5.2.3 Advancement in technology leading to easy usage
       5.2.4 Increase in number of cancer patients
       5.2.5 Rise in POCT in developed countries
       5.2.6 Increase in usage of anticoagulant therapy
5.3 Restraints
       5.3.1 Lack of awareness in developing countries
       5.3.2 High cost of automated instruments
       5.3.3 Regulatory challenges
5.4 Opportunities
       5.4.1 Focusing on New Product Development
       5.4.2 Mergers and Acquisitions and Strategic Alliances
5.5 Key Trends
5.6 Hemostasis Diagnostics Market: Porter’s Five Forces Analysis 
5.7 Hemostasis Diagnostics Market: Value Chain Analysis 
5.8 Coagulation Disorders & Coagulation Pathways: Overview
5.9 Epidemiology: Coagulation Disorders
5.10 Regulatory Framework 
5.11 Reimbursement Scenario 
5.12 Hemostasis Diagnostics Market: Pricing Analysis 

Section 6 Hemostasis Diagnostics Market Analysis, by Product
6.1 Key Findings
6.2 Introduction
6.3 Global Hemostasis Diagnostics Market Value Share Analysis, by Product
6.4 Hemostasis Diagnostics Market Forecast, by Product
       6.4.1 Laboratory Systems
                6.4.1.1 Automated Systems
                6.4.1.2 Semi-automated Systems
                6.4.1.3 Manual Systems 
       6.4.2 Consumables
       6.4.3 Point-of-Care Testing Systems

Section 7 Hemostasis Diagnostics Market Analysis, by Test Type
7.1 Key Findings
7.2 Introduction
7.3 Global Hemostasis Diagnostics Market Value Share Analysis, by Test Type
7.4 Hemostasis Diagnostics Market Forecast, by Test Type
       7.4.1 Prothrombin Test Time (PT)
       7.4.2 Activated partial thromboplastin time (APTT)
       7.4.3 Fibrinogen degradation products (FDP)
       7.4.4 Activated Clotting Time
       7.4.5 Platelet Aggregation Test 
       7.4.6 D Dimer
       7.4.7 Others
7.5 Market Attractiveness Analysis, by Test Type

Section 8 Hemostasis Diagnostics Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Hemostasis Diagnostics Market Value Share Analysis, by End-user
8.4 Global Hemostasis Diagnostics Market Forecast, by End-user
       8.4.1 Hospital/Clinics
       8.4.2 Independent Diagnostic Laboratories
       8.4.3 Home Care Settings
       8.4.5 Others
8.5 Market Attractiveness Analysis, by End-user

Section 9 Hemostasis Diagnostics Market Analysis, by Region
9.1 Global Hemostasis Diagnostics Market, Global Market Scenario
9.2 Global Hemostasis Diagnostics Market Value Share Analysis, by Region
9.3 Hemostasis Diagnostics Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Hemostasis Diagnostics Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Product
       10.3.1 Market Value Share Analysis, by Product
       10.3.2 Market Size (US$ Mn) Forecast, by Product
                10.3.2.1 Laboratory Systems
                           10.3.2.1.1 Automated Systems
                           10.3.2.1.2 Semi-automated Systems
                           10.3.2.1.3 Manual Systems 
                10.3.2.2 Consumables
                10.3.2.3 Point-of-Care Testing Systems
10.4 Market Analysis, by Test Type
       10.4.1 Market Value Share Analysis, by Test Type
       10.4.2 Market Size (US$ Mn) Forecast, by Test Type
                10.4.2.1 Prothrombin Test Time (PT)
                10.4.2.2 Activated partial thromboplastin time (APTT)
                10.4.2.3 Fibrinogen degradation products (FDP)
                10.4.2.4 Activated Clotting Time
                10.4.2.5 Platelet Aggregation Test 
                10.4.2.6 D Dimer
                10.4.2.7 Others
10.4 Market Analysis, by End-user
       10.4.1 Market Value Share Analysis, by End-user
       10.4.2 Market Size (US$ Mn) Forecast, by End-user
                10.4.2.1 Hospital/Clinics
                10.4.2.2 Independent Diagnostic Laboratories
                10.4.2.3 Home Care Settings
                10.4.2.4 Others
10.5 Market Analysis, by Country
       10.5.1 Market Value Share Analysis, by Country
       10.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
                10.5.2.1 U.S.
                10.5.2.2 Canada
10.6 Market Attractiveness Analysis
       10.6.1 by Product
       10.6.2 by Test Type
       10.6.3 by End-user

Section 11 Europe Hemostasis Diagnostics Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Product
       11.3.1 Market Value Share Analysis, by Product
       11.3.2 Market Size (US$ Mn) Forecast, by Product
                11.3.2.1 Laboratory Systems
                           11.3.2.1.1 Automated Systems
                           11.3.2.1.2 Semi-automated Systems
                           11.3.2.1.3 Manual Systems 
                11.3.2.2 Consumables
                11.3.2.3 Point-of-Care Testing Systems
11.4 Market Analysis, by Test Type
       11.4.1 Market Value Share Analysis, by Test Type
       11.4.2 Market Size (US$ Mn) Forecast, by Test Type
                11.4.2.1 Prothrombin Test Time (PT)
                11.4.2.2 Activated partial thromboplastin time (APTT)
                11.4.2.3 Fibrinogen degradation products (FDP)
                11.4.2.4 Activated Clotting Time
                11.4.2.5 Platelet Aggregation Test 
                11.4.2.6 D Dimer
                11.4.2.7 Others
11.4 Market Analysis, by End-user
       11.4.1 Market Value Share Analysis, by End-user
       11.4.2 Market Size (US$ Mn) Forecast, by End-user
                11.4.2.1 Hospital/Clinics
                11.4.2.2 Independent Diagnostic Laboratories
                11.4.2.3 Home Care Settings
                11.4.2.4 Others
11.5 Market Analysis, by Country
       11.5.1 Market Value Share Analysis, by Country
       11.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
                11.5.2.1 UK
                11.5.2.2 Germany
                11.5.2.3 France
                11.5.2.4 Italy
                11.5.2.5 Spain
                11.5.2.6 Rest of Europe
11.6 Market Attractiveness Analysis
       11.6.1 by Product
       11.6.2 by Test Type
       11.6.3 by End-user

Section 12 Asia Pacific Hemostasis Diagnostics Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Product
       12.3.1 Market Value Share Analysis, by Product
       12.3.2 Market Size (US$ Mn) Forecast, by Product
                12.3.2.1 Laboratory Systems
                           12.3.2.1.1 Automated Systems
                           12.3.2.1.2 Semi-automated Systems
                           12.3.2.1.3 Manual Systems 
                12.3.2.2 Consumables
                12.3.2.3 Point-of-Care Testing Systems
12.4 Market Analysis, by Test Type
       12.4.1 Market Value Share Analysis, by Test Type
       12.4.2 Market Size (US$ Mn) Forecast, by Test Type
                12.4.2.1 Prothrombin Test Time (PT)
                12.4.2.2 Activated partial thromboplastin time (APTT)
                12.4.2.3 Fibrinogen degradation products (FDP)
                12.4.2.4 Activated Clotting Time
                12.4.2.5 Platelet Aggregation Test 
                12.4.2.6 D Dimer
                12.4.2.7 Others
12.4 Market Analysis, by End-user
       12.4.1 Market Value Share Analysis, by End-user
       12.4.2 Market Size (US$ Mn) Forecast, by End-user
                12.4.2.1 Hospital/Clinics
                12.4.2.2 Independent Diagnostic Laboratories
                12.4.2.3 Home Care Settings
                12.4.2.4 Others
12.5 Market Analysis, by Country
       12.5.1 Market Value Share Analysis, by Country
       12.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
                12.5.2.1 Japan
                12.5.2.2 China
                12.5.2.3 India
                12.5.2.4 Australia
                12.5.2.5 Rest of APAC
12.6 Market Attractiveness Analysis
       12.6.1 by Product
       12.6.2 by Test Type
       12.6.3 by End-user

Section 13 Latin America Hemostasis Diagnostics Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Product
       13.3.1 Market Value Share Analysis, by Product
       13.3.2 Market Size (US$ Mn) Forecast, by Product
                13.3.2.1 Laboratory Systems
                           13.3.2.1.1 Automated Systems
                           13.3.2.1.2 Semi-automated Systems
                           13.3.2.1.3 Manual Systems 
                13.3.2.2 Consumables
                13.3.2.3 Point-of-Care Testing Systems
13.4 Market Analysis, by Test Type
       13.4.1 Market Value Share Analysis, by Test Type
       13.4.2 Market Size (US$ Mn) Forecast, by Test Type
                13.4.2.1 Prothrombin Test Time (PT)
                13.4.2.2 Activated partial thromboplastin time (APTT)
                13.4.2.3 Fibrinogen degradation products (FDP)
                13.4.2.4 Activated Clotting Time
                13.4.2.5 Platelet Aggregation Test 
                13.4.2.6 D Dimer
                13.4.2.7 Others
13.4 Market Analysis, by End-user
       13.4.1 Market Value Share Analysis, by End-user
       13.4.2 Market Size (US$ Mn) Forecast, by End-user
                13.4.2.1 Hospital/Clinics
                13.4.2.2 Independent Diagnostic Laboratories
                13.4.2.3 Home Care Settings
                13.4.2.4 Others
13.5 Market Analysis, by Country
       13.5.1 Market Value Share Analysis, by Country
       13.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
                13.5.2.1 Brazil
                13.5.2.2 Mexico
                13.5.2.3 Rest of LATAM
13.6 Market Attractiveness Analysis
       13.6.1 by Product
       13.6.2 by Test Type
       13.6.3 by End-user

Section 14 Middle East & Africa Hemostasis Diagnostics Market Analysis
14.1 Regional Outlook
14.2 Market Overview
14.3 Market Analysis, by Product
       14.3.1 Market Value Share Analysis, by Product
       14.3.2 Market Size (US$ Mn) Forecast, by Product
                14.3.2.1 Laboratory Systems
                           14.3.2.1.1 Automated Systems
                           14.3.2.1.2 Semi-automated Systems
                           14.3.2.1.3 Manual Systems 
                14.3.2.2 Consumables
                14.3.2.3 Point-of-Care Testing Systems
14.4 Market Analysis, by Test Type
       14.4.1 Market Value Share Analysis, by Test Type
       14.4.2 Market Size (US$ Mn) Forecast, by Test Type
                14.4.2.1 Prothrombin Test Time (PT)
                14.4.2.2 Activated partial thromboplastin time (APTT)
                14.4.2.3 Fibrinogen degradation products (FDP)
                14.4.2.4 Activated Clotting Time
                14.4.2.5 Platelet Aggregation Test 
                14.4.2.6 D Dimer
                14.4.2.7 Others
14.4 Market Analysis, by End-user
       14.4.1 Market Value Share Analysis, by End-user
       14.4.2 Market Size (US$ Mn) Forecast, by End-user
                14.4.2.1 Hospital/Clinics
                14.4.2.2 Independent Diagnostic Laboratories
                14.4.2.3 Home Care Settings
                14.4.2.4 Others
14.5 Market Analysis, by Country
       14.5.1 Market Value Share Analysis, by Country
       14.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
                14.5.2.1 South Africa
                14.5.2.2 GCC Countries
                14.5.2.3 Rest of MEA
14.6 Market Attractiveness Analysis
       14.6.1 by Product
       14.6.2 by Test Type
       14.6.3 by End-user

Section 15 Company Profiles
15.1 Hemostasis Diagnostics Market Share Analysis, by Company (2016)
15.2 Company Profiles
       15.2.1 Abbott Laboratories 
                15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.1.2 Financial Overview
                15.2.1.3 Product Portfolio
                15.2.1.4 SWOT Analysis
                15.2.1.5 Strategic Overview
       15.2.2 Alere, Inc.
                15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.2.2 Financial Overview
                15.2.2.3 Product Portfolio
                15.2.2.4 SWOT Analysis
                15.2.2.5 Strategic Overview  
       15.2.3 Thermo Fisher Scientific, Inc.
                15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.3.2 Financial Overview
                15.2.3.3 Product Portfolio
                15.2.3.4 SWOT Analysis
                15.2.3.5 Strategic Overview 
       15.2.4 F. Hoffmann-La Roche Ltd. 
                15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.4.2 Financial Overview
                15.2.4.3 Product Portfolio
                15.2.4.4 SWOT Analysis
                15.2.4.5 Strategic Overview
       15.2.5 Nihon Kohden Corporation 
                15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.5.2 Financial Overview
                15.2.5.3 Product Portfolio
                15.2.5.4 SWOT Analysis
                15.2.5.5 Strategic Overview
       15.2.6 Sysmex Corporation 
                15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.6.2 Financial Overview
                15.2.6.3 Product Portfolio
                15.2.6.4 SWOT Analysis
                15.2.6.5 Strategic Overview
       15.2.7 Siemens Healthineers
                15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.7.2 Financial Overview
                15.2.7.3 Product Portfolio
                15.2.7.4 SWOT Analysis
                15.2.7.5 Strategic Overview
       15.2.8 Instrumentation Laboratory
                15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.8.2 Financial Overview
                15.2.8.3 Product Portfolio
                15.2.8.4 SWOT Analysis
                15.2.8.5 Strategic Overview
       15.2.9 Danaher Corporation (Beckman Coulter)
                15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.9.2 Financial Overview
                15.2.9.3 Product Portfolio
                15.2.9.4 SWOT Analysis
                15.2.9.5 Strategic Overview
       15.2.10 Grifols, S.A. Preface 
                15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
                15.2.10.2 Financial Overview
                15.2.10.3 Product Portfolio
                15.2.10.4 SWOT Analysis
                15.2.10.5 Strategic Overview

List of Tables

Table 01: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 03: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 05: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 06: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 07: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 08: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 09: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 10: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 11: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 12: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 13: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 14: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 15: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 16: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 17: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 18: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 19: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 20: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 22: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 23: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 24: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

List of Figures

Figure 01: Hemostasis Diagnostics Market Snapshot
Figure 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 03: Market Value Share By Product (2016)
Figure 04: Market Value Share By End-user (2016)
Figure 05: Market Value Share By Region(2016)
Figure 06: Global Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 07: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laboratory Systems, 2015–2025
Figure 08: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2015–2025
Figure 09: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Point-of-care Testing Systems, 2015–2025
Figure 10: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Systems, 2015–2025
Figure 11: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Semi-automated Systems, 2015–2025
Figure 12: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Manual Systems, 2015–2025
Figure 13: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Product
Figure 14: Global Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 15: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prothrombin Time (PT), 2015–2025
Figure 16: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT, 2015–2025
Figure 17: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fibrinogen Degradation Products (FDP), 2015–2025
Figure 18: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Activated Clotting Time, 2015–2025
Figure 19: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Platelet Aggregation Test, 2015–2025
Figure 20: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by D Dimer, 2015–2025
Figure 21: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 22: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
Figure 23: Global Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 24: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital & Clinics, 2015–2025
Figure 25: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Diagnostic Laboratories, 2015–2025
Figure 26: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care Settings, 2015–2025
Figure 27: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
Figure 29: Global Hemostasis Diagnostics Market Value Share Analysis, by Region, 2016 and 2025
Figure 30: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Region
Figure 31: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2017–2025
Figure 32: North America Hemostasis Diagnostics Market Attractiveness Analysis, by Country
Figure 33: North America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 34: North America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 35: North America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 36: North America Hemostasis Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Hemostasis Diagnostics Market Attractiveness, by Product
Figure 38: North America Hemostasis Diagnostics Market Attractiveness, by Test Type
Figure 39: North America Hemostasis Diagnostics Market Attractiveness, by End-user
Figure 40: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2017–2025
Figure 41: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Country
Figure 42: Europe Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 43: Europe Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 44: Europe Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 45: Europe Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 46: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Product
Figure 47: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
Figure 48: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
Figure 49: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 50: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Country 2017-2025
Figure 51: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 53: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 54: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 55: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Product
Figure 56: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
Figure 57: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
Figure 58: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 59: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2017–25
Figure 60: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 61: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 62: Latin America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 63: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 64: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Product
Figure 65: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
Figure 66: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
Figure 67: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region
Figure 69: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 70: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 71: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 72: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 73: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Product
Figure 74: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
Figure 75: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
Figure 76: Global Hemostasis Diagnostics Market Share Analysis, by Company (2016)